L.M., B.C. Jones, D.A. Frederick, M.G. Haselton, I.S. Penton-Voak, and D.I. Perrett. “Evidence for menstrual cycle shifts in women’s preferences for masculinity: a response to Harris (in press) ‘menstrual cycle and facial preferences reconsidered.’” Evolutionary Psychology 8, no. 4 (2010): 768–775; Little, Anthony C., Robert P. Burriss, Marion Petrie, Benedict C. Jones, and S. Craig Roberts. “Oral contraceptive use in women changes preferences for male facial masculinity and is associated with partner facial masculinity.” Psychoneuroendocrinology 38, no. 9 (2013): 1777–1785; Peterson, Ashley, Rachael Carmen, and Glenn Geher. “Ovulatory shifts in mating intelligence.” Journal of Social, Evolutionary, and Cultural Psychology 7, no. 1 (2013): 66.

70. Ober, C., S. Elias, D.D. Kostyu, and W.W. Hauck. “Decreased fecundability in Hutterite couples sharing HLA-DR.” American Journal of Human Genetics 50, no. 1 (1992): 9–13.

71. Ober, Carole, Terry Hyslop, Sherman Elias, Lowell R. Weitkamp, and Walter W. Hauck. “Human leukocyte antigen matching and fetal loss: results of a 10 year prospective study.” Human Reproduction 13, no. 1 (1998): 35–37; Beydoun, H., and A.F. Saftlas. “Association of human leucocyte antigen sharing with recurrent spontaneous abortions.” Tissue Antigens 65, no. 2 (2005): 123–35.

72. Alvergne, Alexandra, and Virpi Lummaa. “Does the contraceptive pill alter mate choice in humans?” Trends in Ecology & Evolution 25, no. 3 (2010): 2–4; Kuukasjärvi, Seppo, C.J. Peter Eriksson, Esa Koskela, Tapio Mappes, Kari Nissinen, and Markus J. Rantala. “Attractiveness of women’s body odors over the menstrual cycle: the role of oral contraceptives and receiver sex.” Behavioral Ecology 15, no. 4 (2004): 579–584; Puts, David A., Drew H. Bailey, Rodrigo A. Cárdenas, Robert P. Burriss, Lisa L.M. Welling, John R. Wheatley, and Khytam Dawood. “Women’s attractiveness changes with estradiol and progesterone across the ovulatory cycle.” Hormones and Behavior 63, no. 1 (2013): 13–19.

73. Rosvall, Kimberly A. “Intrasexual competition in females: evidence for sexual selection?” Behavioral Ecology (2011): arr106; Cobey, Kelly D., Christine Klipping, and Abraham P. Buunk. “Hormonal contraceptive use lowers female intrasexual competition in pair-bonded women.” Evolution and Human Behavior 34, no. 4 (2013): 294–298.

74. Miller, Geoffrey, Joshua M. Tybur, and Brent D. Jordan. “Ovulatory cycle effects on tip earnings by lap dancers: economic evidence for human estrus?” Evolution and Human Behavior 28, no. 6 (2007): 375–381.

75. Webb, J.L. “Nutritional effects of oral contraceptive use: a review.” The Journal of Reproductive Medicine 25, no. 4 (1980): 150–156; Shojania, A. Majid. “Oral contraceptives: effect of folate and vitamin B12 metabolism.” Canadian Medical Association Journal 126, no. 3 (1982): 244; Li, X., J. Ran, and H. Rao. “Megaloblastic changes in cervical epithelium associated with oral contraceptives and changes after treatment with folic acid.” Chinese Journal of Obstetrics and Gynecology 30, no. 7 (1995): 410–413; Albright, F., A.M. Butler, A.O. Hampton, P. Smith, M.B. Dockerty, R.K. Ghormley, R.L.J. Kennedy, and D.G. Pugh. “The pill and folate metabolism.” The BMJ (1971); Shere, Mahvash, Priya Bapat, Cheri Nickel, Bhushan Kapur, and Gideon Koren. “Association between use of oral contraceptives and folate status: a systematic review and meta-analysis.” Journal of Obstetrics and Gynaecology Canada 37, no. 5 (2015): 430–438; Bielenberg, J. “Folic acid and vitamin deficiency caused by oral contraceptives.” Medizinische Monatsschrift fur Pharmazeuten 14, no. 8 (1991): 244–247.

76. Shere, Mahvash, Priya Bapat, Cheri Nickel, Bhushan Kapur, and Gideon Koren. “Association between use of oral contraceptives and folate status: a systematic review and meta-analysis.” Journal of Obstetrics and Gynaecology Canada 37, no. 5 (2015): 430–438.

77. Там же.

78. Green, Timothy J., Lisa A. Houghton, Ursula Donovan, Rosalind S. Gibson, and Deborah L. O’Connor. “Oral contraceptives did not affect biochemical folate indexes and homocysteine concentrations in adolescent females.” Journal of the American Dietetic Association 98, no. 1 (1998): 49–55; McWilson, Stephanie, Brittney N. Bivins, Katelyn A. Russell, and Lynn B. Bailey. “Oral contraceptive use: impact on folate, vitamin B6, and vitamin B12 status.” Nutrition Reviews 69, no. 10 (2011): 572–583; McArthur, Jennifer O., HoMan Tang, Peter Petocz, and Samir Samman. “Biological variability and Impact of oral contraceptives on vitamins B6, B12 and folate status in women of reproductive age.” Nutrients 5, no. 9 (2013): 3634–3645; Sütterlin, Marc W., Stefanie S. Bussen, Lorenz Rieger, Johannes Dietl, and Thomas Steck. “Serum folate and Vitamin B12 levels in women using modern oral contraceptives (OC) containing 20 μg ethinyl estradiol.” European Journal of Obstetrics & Gynecology and Reproductive Biology 107, no. 1 (2003): 57–61; Mountifield, J.A. “Serum vitamin B12 and folate levels in women taking oral contraceptives.” Canadian Family Physician 32 (1986): 862–865.

79. Mountifield, J.A. “Serum vitamin B12 and folate levels in women taking oral contraceptives.” Canadian Family Physician 32 (1986): 863; McArthur, Jennifer O., HoMan Tang, Peter Petocz, and Samir Samman. “Biological variability and Impact of oral contraceptives on vitamins B6, B12 and folate status in women of reproductive age.” Nutrients 5, no. 9 (2013): 3639–3643; Palmery, M., A. Saraceno, A. Vaiarelli, and G. Carlomagno. “Oral contraceptives and changes in nutritional requirements.” European Review for Medical and Pharmacological Sciences 17, no. 13 (2013): 1804–1813.

80. McArthur, Jennifer O., HoMan Tang, Peter Petocz, and Samir Samman. “Biological variability and Impact of oral contraceptives on vitamins B6, B12 and folate status in women of reproductive age.” Nutrients 5, no. 9 (2013): 3634–3645; Sütterlin, Marc W., Stefanie S. Bussen, Lorenz Rieger, Johannes Dietl, and Thomas Steck. “Serum folate and Vitamin B12 levels in women using modern oral contraceptives (OC) containing 20 μg ethinyl estradiol.” European Journal of Obstetrics & Gynecology and Reproductive Biology 107, no. 1 (2003): 57–61; Green, Timothy J., Lisa A. Houghton, Ursula Donovan, Rosalind S. Gibson, and Deborah L. O’Connor. “Oral contraceptives did not affect biochemical folate indexes and homocysteine concentrations in adolescent females.” Journal of the American Dietetic Association 98, no. 1 (1998): 49–55.

81. Lassi, Zohra S., and Zulfiqar A. Bhutta. “Clinical utility of folate-containing oral contraceptives.” International Journal of Women’s Health 4 (2012): 185–190; Taylor, Thomas N., Raymond A. Farkouh, Jonathan B. Graham, Antje Colligs, Marion Lindemann, Richard Lynen, and Sean D. Candrilli. “Potential reduction in neural tube defects associated with use of Metafolin-fortified oral contraceptives in the United States.” American Journal of Obstetrics and Gynecology 205,